Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Takeda Pharamaceutical Company Limited
483
•Takeda Pharamaceutical Company Limited•June 6, 2025

Takeda Pharamaceutical Company Limited – FDA 483, Jun 6, 2025

Record Details

An FDA inspection conducted at Takeda Pharmaceutical Company Limited's Longmont, CO Source Plasma Center from June 2-6, 2025, revealed significant issues with equipment standardization and calibration practices. The observations, reported under Section 704(b) of the Federal Food, Drug and Cosmetic Act, highlight a lack of adherence to established operational procedures and manufacturer guidelines for critical equipment used in blood and blood component collection and processing. Specifically, the inspection noted two instances of non-compliance. First, an employee failed to properly perform quality control checks on plasmapheresis machines, neglecting to tare the weigh scale before testing with calibrated weights, a step explicitly required by the firm's standard operating procedure and the operator's manual. Second, a review of records indicated that a plasma protein refractometer, essential for daily quality control, was not handled correctly after an out-of-range test result. Instead of removing the instrument from service and contacting a representative as instructed by the manufacturer's guide, an employee repeatedly re-tested until an "in-range" result was achieved, then approved the instrument for use. These observations necessitate prompt corrective actions by Takeda to ensure compliance with regulatory standards and the integrity of their plasma collection processes.

Company
Takeda Pharamaceutical Company Limited
Inspection date
June 6, 2025
Product type
biologics
Office
Denver District Office
Person
  • David A. Moore
View Company Profile

ID · c9217b81-a0af-4378-84ba-1846ffb8f542

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Takeda Pharamaceutical Company Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.